HSP90 Activators are a diverse group of chemical compounds that, while initially acting as inhibitors, ultimately serve to enhance the functional activity of HSP90 through indirect mechanisms. Geldanamycin, and its derivative 17-AAG, along with other HSP90 inhibitors like Radicicol, Novobiocin, and STA-9090, bind to the ATP-binding site of HSP90, which leads to an initial inhibition of the protein's chaperone activity.This can initiate a compensatory heat shock response mediated by the activation of heat shock factor 1 (HSF1), resulting in the upregulation and increased functional activity of HSP90 and its client proteins. Similarly, PU-H71, BIIB021, Luminespib, and Onalespib all target the ATP-binding domain of HSP90, leading to the degradation of client proteins that rely on HSP90's chaperone function. This degradation, in turn, triggers a cellular heat shock response that enhances the expression and activity of HSP90, thereby indirectly increasing its capacity to stabilize and activate a wide array of client proteins involved in critical cellular processes.
Contributing to this ensemble of HSP90 activators are Debio 0932, SNX-2112, and the naturally occurring Zerumbone, which also function by binding to HSP90 and inducing a stress response within the cell. Debio 0932 and SNX-2112 engage the N-terminal ATP-binding domain of HSP90, whereas Zerumbone is thought to induce the heat shock response through a different mechanism, possibly by influencing HSF1 directly. Despite the initial inhibitory interaction, these compounds collectively lead to a stronger and more active HSP90 complex. The enhanced expression of HSP90 and its chaperoning efficiency ensure the proper folding, stability, and function of a multitude of proteins, many of which play pivotal roles in cell signaling, proliferation, and survival. Through these intricate biochemical mechanisms, the listed HSP90 activators indirectly but effectively elevate the functional activity of HSP90, ensuring the maintenance of cellular proteostasis under stress conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin is an ansamycin antibiotic that binds to the ATP binding site of HSP90, thereby inhibiting its chaperone activity. This paradoxically leads to the activation of heat shock factor 1 (HSF1) and subsequent upregulation of HSP90 expression and its client proteins, enhancing their stability and functional activity. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Similar to Geldanamycin, 17-AAG is a benzoquinone ansamycin antibiotic that binds to the N-terminal ATP-binding pocket of HSP90, inhibiting its function. This results in the activation of the heat shock response, which indirectly increases the levels and activity of HSP90 and its associated client proteins. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
Radicicol, a macrocyclic antifungal antibiotic, also targets the ATP binding site of HSP90, leading to the activation of HSF1. The heat shock response triggered by Radicicol results in the upregulation of HSP90 and its chaperone activity towards client proteins. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Novobiocin is a coumarin antibiotic that binds to the C-terminal domain of HSP90, which interferes with its chaperone function. This perturbation can stimulate a compensatory heat shock response, enhancing the expression and activity of HSP90 and client proteins. | ||||||
Ganetespib | 888216-25-9 | sc-364496 sc-364496A | 10 mg 250 mg | $273.00 $1040.00 | ||
STA-9090 is a triazolone compound that binds to the ATP-binding domain of HSP90, leading to degradation of its client proteins. However, this also stimulates a heat shock response, indirectly enhancing the level and activity of HSP90. | ||||||
NVP-AUY922 | 747412-49-3 | sc-364551 sc-364551A sc-364551B sc-364551C sc-364551D sc-364551E | 5 mg 25 mg 100 mg 250 mg 1 g 5 g | $150.00 $263.00 $726.00 $1400.00 $2900.00 $11000.00 | 3 | |
Luminespib is a synthetic isoxazole HSP90 inhibitor that binds to the N-terminal ATP-binding site of HSP90. Its action induces a heat shock response that enhances the expression and functional activity of HSP90. | ||||||
Zerumbone | 471-05-6 | sc-364148 sc-364148A | 10 mg 50 mg | $112.00 $408.00 | ||
Zerumbone, a natural cyclic sesquiterpene, has been shown to induce a heat shock response. This activation of HSF1 can lead to increased expression and activity of HSP90, indirectly enhancing its chaperone function for various proteins. | ||||||